logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10272179 B1

PDFFull Text
Date of Patent:
Apr. 30, 2019

Filed:

Aug. 16, 2017

Encapsulation of pancreatic cells derived from human pluripotent stem cells

Applicant:

Viacyte, Inc., San Diego, CA (US);

Inventors:

Laura Martinson, San Diego, CA (US);

Chad Green, San Diego, CA (US);

Evert Kroon, San Diego, CA (US);

Emmanuel Edward Baetge, San Diego, CA (US);

Assignee:

ViaCyte, Inc., San Diego, CA (US);

Attorney:

Klarquist Sparkman, LLP

Primary Examiner:

Shin Lin Chen

Int. Cl.
CPC ...
A61F 2/00 (2006.01); A61M 31/00 (2006.01); A61M 37/00 (2006.01); C12N 5/071 (2010.01); A61L 27/38 (2006.01); A61K 35/39 (2015.01); A61L 27/14 (2006.01); A61L 27/54 (2006.01); A01N 1/02 (2006.01); A61K 38/28 (2006.01); A61M 5/00 (2006.01); A61F 2/02 (2006.01); A61L 27/50 (2006.01); A61L 27/56 (2006.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61L 27/3804 (2013.01); A01N 1/0221 (2013.01); A61F 2/022 (2013.01); A61K 35/39 (2013.01); A61K 38/28 (2013.01); A61L 27/14 (2013.01); A61L 27/50 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); A61M 5/00 (2013.01); A61M 31/002 (2013.01); C12N 5/0676 (2013.01); C12N 5/0678 (2013.01); A61K 2035/126 (2013.01); A61L 2300/252 (2013.01); A61L 2300/62 (2013.01); A61L 2300/64 (2013.01); A61M 31/00 (2013.01); A61M 2202/07 (2013.01); A61M 2205/04 (2013.01); C12N 2501/115 (2013.01); C12N 2501/117 (2013.01); C12N 2501/119 (2013.01); C12N 2501/16 (2013.01); C12N 2501/19 (2013.01); C12N 2501/385 (2013.01); C12N 2501/41 (2013.01); C12N 2501/415 (2013.01); C12N 2506/02 (2013.01);
Abstract

The present invention relates to a perforated semi-permeable device comprising, human pancreatic endocrine cells or human PDX1-positive pancreatic endoderm cells contained within a semi-permeable membrane comprising a synthetic material, wherein the synthetic material is polysulfone (PSF), nano-fiber mats, polyimide, tetrafluoroethylene/polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), polyacrylonitrile, polyethersulfone, acrylic resin, cellulose acetate, cellulose nitrate, polyamide, or hydroxylpropyl methyl cellulose (HPMC), a cell encapsulation chamber, and at least one seal that is within the cell encapsulation chamber.

Find Patent Forward Citations

Loading…